On Monday, Pfizer announced that it's launching an accelerated Phase 2/3 trial for a COVID prophylactic pill designed to ward off COVID in those may have come in contact with the disease.
In other news, Pfizer is testing Ivermectin, now renamed PF-07321332, to help with Covid.
Krena September 27, 2021After a crafted "Horse dewormer" smear campaigns on a 35yr old safe, effective, off-label drug, i.e. Ivermectin, media brazenly started to praise unproven pills for which Pfizer & Merck are pushing EUA following that of experimental vaccines.
According to Reuters, Pfizer said on Monday it has "Started a large study testing its investigational oral antiviral drug for the prevention of COVID-19 infection among those who have been exposed to the virus."
Pfizer isn't the only drugmaker hoping to develop a prophylactic treatment for COVID exposure.
Reuters explains that the mid-to-late-stage study will test the Pfizer drug's - known as PF-07321332 ability to prevent COVID symptoms in up to 2,660 healthy adult participants aged 18 and older who live in the same household as an individual with a confirmed symptomatic COVID infection.
At present, Gilead's much-hyped but not-all-that-effective IV drug remdesivir is the only approved antiviral treatment for COVID in the US. Several antibody cocktails have also been widely tested and trials are ongoing - including Merck and partner Ridgeback Biotherapeutics, which recently launched a late-stage trial for experimental COVID prophylactic, molnupiravir.
It's becoming increasingly difficult to discern fact from fiction, and unfortunately the media has a strong bias. They spin stories to make conservatives look bad and will go to great lengths to avoid reporting on the good that comes from conservative policies. There are a few shining lights in the media landscape-brave conservative outlets that report the truth and offer a different perspective. We must support conservative outlets like this one and ensure that our voices are heard.
No comments:
Post a Comment